News in brief: What future for COVID-19 Global Rheumatology Alliance? csDMARD/TNFi comedication improves PsA remission rates; Rebound fractures after stopping denosumab

What next for COVID-19 Global Rheumatology Alliance? Take the survey More than a year after its inception, the COVID-19 Global Rheumatology Alliance is looking to the future and seeking ideas from health professionals about what the Alliance could become after the need to address the pandemic has receded. The grassroots initiative of clinical and academic ...

Already a member?

Login to keep reading.

© 2021 the limbic